Ex-PRESS miniature glaucoma device in vitrectomized eyes

Eur J Ophthalmol. 2010 Sep-Oct;20(5):945-7. doi: 10.1177/112067211002000521.


Purpose: To evaluate the clinical efficacy and safety of the Ex-PRESS miniature glaucoma device placed under scleral flap for the treatment of ocular hypertension in eyes that underwent vitreoretinal surgery.

Methods: Vitrectomized patients who required glaucoma surgery for persistent ocular hypertension were included. The Ex-PRESS miniature glaucoma device was implanted under scleral flap. Postsurgical clinical outcomes and intraocular pressure (IOP) was monitored for 6 months after surgery.

Results: At 6 months, all the patients had an IOP lower than 18 mmHg, 3 of them without topical therapy.

Conclusions: The use of the Ex-PRESS implant under scleral flap in eyes that underwent vitreoretinal surgery was effective for lowering IOP.

Publication types

  • Case Reports

MeSH terms

  • Adolescent
  • Adult
  • Aged
  • Female
  • Glaucoma Drainage Implants*
  • Humans
  • Intraocular Pressure / physiology
  • Male
  • Ocular Hypertension / physiopathology
  • Ocular Hypertension / surgery*
  • Prosthesis Implantation
  • Sclera / surgery*
  • Surgical Flaps
  • Treatment Outcome
  • Vitrectomy*